Last updated 2026-11-09
- Raised $8M Series D led by Guangzhou-Israel Biotechnology Fund (GIBF), Jun 2026
- Raised $15M Series C led by Deep Insight, Nov 2021
- Raised $17M Series B led by Israel Biotech Fund, Jan 2019
Total raised
$45.0M
Last: Undisclosed Round 2026-06
Stage
Series C
Founded
2016
Headcount
38
HQ
Misgav, Israel
Sector
Health Tech & Life Sciences
About
Biond Biologics is an Israeli clinical-stage biopharmaceutical company focused on developing breakthrough immunotherapies and a pioneering intracellular drug delivery platform for cancer treatment. The company's approach involves targeting novel immune evasion mechanisms and utilizing its INspire platform for intracellular delivery of biologics. Biond aims to translate high-quality science into transformative drugs for diseases with high unmet needs. Their pipeline includes clinical-stage oncology programs and a portfolio of discovery and preclinical programs in immune-mediated diseases.
Funding history · 4 rounds · $45.0M total
4 events/rounds · $45.0M Total Funding: $44.4M in Private Equity
Jun 2026
Nov 2021
Jan 2019
Apr 2016
A Round
$4.4M
prior (startupim db)
Offices
Misgav, Israel · HQ / main office
Q&A
- What is Biond Biologics' primary focus?
- Biond Biologics is a clinical-stage biopharmaceutical company that develops first-in-class immunotherapies for cancer and immune-mediated diseases. They also have a pioneering intracellular drug delivery platform for cancer treatment.
- When was Biond Biologics founded and where is it headquartered?
- Biond Biologics was founded in April 2016 and is headquartered in Misgav, Israel.
- How much funding has Biond Biologics raised in total?
- Biond Biologics has raised a total of $45,000,000 across multiple funding rounds.
- When did Biond Biologics complete its Series A funding round and who were the lead investors?
- In April 2016, Biond Biologics completed its Series A funding round, raising $4,400,000. Lead investors included Celgene and Harel Group
- When did Biond Biologics complete its Series B funding round and who were the lead investors?
- In January 2019, Biond Biologics completed its Series B funding round, raising $17,000,000. Lead investors included Israel Biotech Fund and Celgene Corporation.
- When did Biond Biologics complete its Series C funding round and who was the lead investor?
- In November 2021, Biond Biologics completed its Series C funding round, raising $15,000,000. Deep Insight was the lead investor.
- When did Biond Biologics complete its Series D funding round and who was the lead investor?
- In June 2026, Biond Biologics completed its Series D funding round, raising $8,000,000. Guangzhou-Israel Biotechnology Fund (GIBF) was the lead investor.
- What is the employee count for Biond Biologics?
- Biond Biologics has an employee count in the 11-50 range.
Team · 16
Tehila Ben Moshe
Founder · Co-Founder, Chairperson & Chief Executive Officer
Ori Shilo
Founder · Co-Founder & Chief Financial Officer
Yair Sapir
Chief Operations Officer
Ilana Mandel
Chief Scientific Officer
Giovanni Selvaggi
Chief Medical Officer
Motti Hakim
VP R&D
Sharon Hashmueli
VP Regulatory Affairs & CMC
Tal Sines
VP Business Development
Nir Brav
VP Finance
Natalia Ashtamker
VP of Clinical Development
Tehila Ben Moshe
Co-Founder, Chairperson & Chief Executive Officer
Ori Shilo
Co-Founder & Chief Financial Officer
Ronit Bendori
Board Member
Yuval Cabilly
Board Member
Tomer Goldberg
Board Member
Barak Ben-Eliezer
Board Member
Sectors & technology
Primary sector
Health Tech & Life Sciences
Technologies
Target customers
Business model
B2BLicensing agreementsPartnerships
Highlights
Patents
Tags
pharmaceuticalsimmunologydrug-discoveryoncologyautoimmune-diseasesbiopharmaceuticalcancerpharma-companiesimmunotherapybiotechnologyhealth-care
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | biondbio.com |
|---|---|
| linkedin.com/company/18156602 |
Identifiers & details
| Legal name | Biond Biologics Ltd. |
|---|---|
| Founded | 2016-4 |
| Employees (exact) | 38 |
Radar intelligence
Patents
| EPO | 18 |
|---|
Web history (Wayback)
| Domain | biondbio.com |
|---|
Certificate / subdomain footprint
| Subdomains | 4 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515445823 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2016-04-21 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 8 — people (1), shares_capital (2), annual_report (5) |
| Registered address | 4 משגב |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-28 | עדכון בעלי תפקידים |
| 2025-12-22 | הקצאת מניות |
| 2025-09-07 | דו~ח שנתי-הקצאת מניות |
| 2025-09-07 | דו~ח שנתי-שינוי בהוראות בתקנון |
| 2025-09-07 | דו~ח שנתי-עדכון תחום עיסוק |
| 2025-09-07 | דו~ח שנתי-הוספת דירקטור |
| 2025-09-07 | דו~ח שנתי-הוספת בעל תפקיד |
| 2026-07-06 | שינוי בהרכב הון - מניות-פיצול מניה |